BEIJING & CAMBRIDGE, Mass.–EdiGene Inc., which develops genome editing technologies into novel therapeutics for a broad range of diseases and into creative solutions to advance drug discovery, today announced the successful completion of approximately $15 Million in a Series pre-B financing. The financing is led by new investor Lilly Asia Ventures (LAV). New investor Huagai […]

Genomic Vision grants European Equity Partner (EEP) a license to its proprietary technology. During the evaluation period, the parties will confirm interest of molecular combing as a genome integrity assay as a quality control tool in biomanufacturing of proteins This strategic collaboration is aimed at building a Bioanalytical Services Company offering specific leading analytical services […]

Oxford – Oxford Genetics, a leader in innovative synthetic biology-based technologies for biologics discovery, development and delivery, has secured a multi-million pound contract with a leading multi-billion dollar global ecommerce provider of reagents and tools to the research and clinical community. As part of the agreement, Oxford Genetics will leverage its high throughput automated genomic engineering […]

Two Leading Centers to Explore Spatial Genomics Synergies with Single-Cell Biology, Next-Generation Sequencing, and Advanced Imaging Technologies Announces Early Access Launch for Five Additional Beta Instruments SEATTLE — NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the company has added two new Centers of Excellence […]

Powerful, flexible and easy-to-use analysis solution gets the most out of NGS data Oxford, UK. Oxford Gene Technology (OGT), The Molecular Genetics Company, has announced the launch of the eagerly-anticipated update to its SureSeq™ Interpret software, included with purchases of SureSeq NGS panels. Designed to help researchers effortlessly translate cumbersome NGS data into meaningful results, OGT has […]

TUCSON, Ariz. — HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a provider of instruments, reagents, and services for molecular profiling applications and Oncologie, Inc. an innovative biotechnology company with operations in Boston and Shanghai, today announced the completion of a master agreement where the companies have agreed to partner on the development of biomarkers associated with […]

Group sales of EUR 335.6 million with organic growth of 8.6 percent in local currencies Operating result increases by 6.4 percent to EUR 67.3 million; EBIT margin of 20.0 percent Enhancements in sales & distribution and accelerated innovation are confirmed as success factors Hamburg – The Eppendorf Group continued to perform well in the first […]

Copenhagen, Denmark – Anapa Biotech (“Anapa”; www.meltplex.com) is a Copenhagen – based company with novel intellectual property and a first-in-class approach to ultrahigh performance multiplexing for molecular diagnostic assays. Following a strategic review and four years of technical development and IP filing, Anapa is pleased to announce that it is working with The Sage Group […]

Day-One Lab Readiness speeds commercialization and reimbursement in personalized medicine Hilden, Germany, and Tokyo, Japan – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced a collaboration with SRL, Inc., the largest clinical testing laboratory company in Japan, to prepare for introduction of new companion diagnostics simultaneous with new drug approvals. The non-exclusive master collaboration agreement for clinical laboratory […]

Covaris and Bioz Have Partnered to Bring Data and Transparency to the Customer Experience    LOS ALTOS, CA – Bioz, Inc., a Silicon Valley AI data company, is proud to announce a new partnership with Covaris, Inc., the gold standard of DNA fragmentation in Next Generation Sequencing. By combining the latest advances in Natural Language Processing […]